Abstract
Development of clinical diabetic nephropathy in IDDM-patients is associated with high excess mortality as well as with generalized vascular lesions and impairment in the cardiovascular risk profile of the individual. It therefore indicates a poor prognosis of the patient.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Borch-Johnsen K. The prognosis of insulin-dependent diabetes mellitus. Dan Med Bull 1989; 36: 336–348.
Diabetes Epidemiology Research International (DERI) Mortality Study Group. Major Cross-Country differences in risk of dying for people with IDDM. Diabetes Care 1991; 14: 49–54.
Watson PJ, Blainey JD, Brewer DB, Fitzgerald MG, Malins JM, O’Sullivan DJ, Pinto JA. The natural history of diabetic renal disease. Q J Med 1972; 164: 437–456.
Borch-Johnsen K, Andersen PK, Deckert T. The effect of proteinuria on relative mortality in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1985; 28: 590–596.
Borch-Johnsen K, Kreiner S, Deckert T. Mortality of Type 1 (insulin-dependent) diabetes mellitus in Denmark. Diabetologia 1986; 29: 767–772.
Kofoed-Enevoldsen A, Borch-Johnsen K, Kreiner S, Nerup J, Deckert T. Declining incidence of persistent proteinuria in Type 1 (insulin-dependent)diabetic patients in Denmark. Diabetes 1987; 36: 205–209.
Krolewski AS, Warram JH, Christlieb ARE, Busick EJ, Kahn CR. The changing natural history of nephropathy in Type 1 diabetes. Am J Med 1985; 78: 785–794.
Viberti GC, Jarrett RJ, Mahmud U, Hill RD, Argyropoulos A, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin dependent diabetes mellitus. Lancet 1982; i: 1430–1432.
Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984; 311: 89–93.
Mathiesen ER, Oxenbøll B, Johansen K, Svendsen PAa, Deckert T. Incipient nephropathy in Type 1 (insulin-dependent) diabetes. Diabetologia 1984; 26: 406–410.
Jensen T. Albuminuria — a marker of renal and generalized vascular disease in insulin-dependent diabetes mellitus. Dan Med Bull 1991; 38: 134–144.
Feldt-Rasmussen B. Microalbuminuria and clinical nephropathy in Type 1 (insulin-dependent) diabetes mellitus: pathophysiological mechanisms and intervention studies. Dan Med Bull 1989; 36: 405–415.
Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989; 32: 216–226.
Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes. N Engl J Med 1984; 310: 356–336.
Jarrett RJ, Viberti GC, Argyropoulos A, Hill RD, Mahmud U, Murrells TJ. Microalbuminuria predicts mortality in non-insulin-dependent diabetes. Diabetic Med 1984; 1: 17–19.
Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Lancet 1988; ii: 530–533.
Damsgaard EM, Frøland A, Jørgensen OD, Mogensen CE. Micro-albuminuria as predictor of increased mortality in elderly people. BMJ 1990; 300: 297–300.
Messent JWC, Elliott TG, Hill RD, Jarrett RJ, Keen H, Viberti GC. Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty year follow-up study. Kidney Int 1992; 41: 836–839.
Marre M, Chatellier G, Leblanc H, Guyene TT, Menard J, Passa P. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. BMJ 1988; 297: 1092–1095.
Mathiesen ER, Hommel E, Giese J, Parving H-H. Efficacy of captopril in postponing nephropathy in normotensive insulin-dependent diabetic patients with microalbuminuria. BMJ 1991; 303: 81–87.
Melbourne Diabetic nephropathy study group. Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. BMJ 1991; 302: 210–216.
Feldt-Rasmussen B, Mathiesen ER, Jensen T, Lauritzen T, Deckert T. Effect of improved metabolic control on loss of kidney function in Type 1 (insulin-dependent) diabetic patients: an update of the Steno studies. Diabetologia 1991; 34: 164–170.
Marshall SM, Albert KGMM. Comparison of the prevalence and associated features of abnormal albumin excretion in insulin-dependent and non-insulin dependent diabetes. Q J Med 1989; 70: 61–71.
Borch-Johnsen K. Predictive value of microalbuminuria in long standing insulin dependent diabetes, (letter) BMJ 1993; 306: 271–272.
Mogensen CE. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. BMJ 1982; 285: 685–688.
Parving H-H, Andersen ARE, Smidt UM, Svendsen PAA. Early aggressive antihypertensive treatment reduces the rate of decline in kidney function in diabetic nephropathy. Lancet 1983; i: 1175–1179.
Mathiesen ER, Borch-Johnsen K, Jensen DV, Deckert T. Improved survival in patients with diabetic nephropathy. Diabetologia 1989; 32: 884–886.
Eggers PW. Health Care Policies/economics of the geriatric renal population. Am J Kidney Dis 1990; 16: 384–391.
Siegel JE, Krolewski AS, Warram JH, Weinstein MC. Cost-effectiveness of screening and early treatment of nephropathy in patients with insulin-dependent diabetes mellitus. J Am Soc Nephrol 1992; 3: 3111–3119.
Borch-Johnsen K, Wenzel H, Viberti GC, Mogensen CE. Is screening and intervention for Microalbuminuria worthwhile in patients with insulin dependent diabetes? BMJ 1993; 306: 1722–1725.
Ramlau-Hansen H, Bang Jespersen NC, Andersen PK, Borch-Johnsen K, Deckert T. Life insurance for insulin-dependent diabetics. Scand Actuarial J 1987; 19-36.
Kiberd BA, Jindal KK. Screening to prevent renal failure in insulin dependent diabetic patients: an economical evaluation. BMJ 1995; 311: 595–599.
Microalbuminuria Collaborative Study Group, UK. Risk factors for development of microalbuminuria in insulin dependent diabetic patients: a cohort study. BMJ 1993; 306: 1235–1239.
Hansen KW, Christensen CK, Andersen PH, Mau Pedersen M, Christiansen JS, Mogensen CE. Ambulatory blood pressure in microalbuminuric type 1 diabetic patients. Kidney Int 1992; 41: 847–854.
Deckert T, Yokoyama H, Mathiesen ER, Rønn B, Jansen T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen JS. Cohort study of predictive value of urinary albumin excretion for atherosclerotic vascular disease in insulin dependent diabetes. BMJ 1996; 312: 871–874.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Borch-Johnsen, K. (1996). Incidence of Nephropathy in Insulin-Dependent Diabetes Mellitus as Related to Mortality and Cost-Benefit of Early Intervention. In: Mogensen, C.E. (eds) The Kidney and Hypertension in Diabetes Mellitus. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-6749-0_11
Download citation
DOI: https://doi.org/10.1007/978-1-4757-6749-0_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-6751-3
Online ISBN: 978-1-4757-6749-0
eBook Packages: Springer Book Archive